Lok Sabha Question No. 2757 (UNSTARRED), answered on 2017-03-17
Subject: World Integrated Medicine Forum
Ministry: AYURVEDA,YOGA & NATUROPATHY,UNANI,SIDDHA AND HOMEOPATHY (AYUSH)
Asked by: T. RADHAKRISHNAN, ASHOK SHANKARRAO CHAVAN, BIDYUT BARAN MAHATO, GAJANAN CHANDRAKANT KIRTIKAR, SUDHEER GUPTA, KUNWAR HARIBANSH SINGH, SUNIL BALIRAM GAIKWAD

## GOVERNMENT OF INDIA MINISTRY OF AYURVEDA, YOGA & NATUROPATHY, UNANI, SIDDHA AND HOMOEOPATHY (AYUSH)

LOK  SABHA UNSTARRED  QUESTION NO. 2757 TO BE ANSWERED ON 17 TH MARCH, 2017

## WORLD INTEGRATED MED ICINE FORUM

2757. SHRI T. RADHAKRISHNAN:

SHRI ASHOK SHANKARRAO CHAVAN:

SHRI BIDYUT BARAN MAHATO:

SHRI GAJANAN KIRTIKAR:

SHRI SUDHEER GUPTA:

KUNWAR HARIBANSH SINGH:

DR. SUNIL BALIRAM GAIKWAD:

Will  the  Minister of AYURVEDA,  YOGA  AND  NATUROPATHY,  UNANI, SIDDHA AND HOMOEOPATHY (AYUSH) be pleas ed to state:

- (a)  whether  the  Government  has  inaugurated  the  World  Integrated  Medicine  Forum  on Regulation of Homoeopathic Medicine products recently, if so, the details thereof alon aims and objectives;
- (b) the name of the countries which have participated in the said Forum;
- (c) the details of the major issues discussed in the Forum and the outcome thereto;
- (d)  the  details  of  Memorandum  of  Understandings  (MoUs)  signed  between Homoeopathic Pharmacopoeia  Conve ntion  of  the  United  States  and  Central  Council  for  Research  i Homoeopathy (CCRH); and
- (e) the steps taken/being taken by the Government to assure safety and quality of homoeo medicines in the country?

## ANSWER

THE MINISTER OF STATE (IC) OF THE MINISTRY OF AYURVEDA, YOGA & NATUROPATHY, UNANI, SIDDHA AND HOMOEOPATHY (SHRI SHRIPAD YESSO NAIK)

- (a): Yes. The 'World Integrated Medicine Forum on Regulation of Homoeopathic Medicinal Products: National and Global strategies'  was  held  on  23 - 24  February,  2017. Major aims and objectives were as under: -
- (i)    to  make  access  to  quality - assured,  GMP - certified,  homoeopathy  drugs  easier  and economical;

Contd……..

- (ii) to harmonize homoeopathic pharmacopeias of di fferent countries;
- (iii) to standardize regulations for homoeopathic medicinal products across the glob
- (iv) to enable regular meetings of key global stakeholders like drug regulators, manufacturers and pharmacopeia experts from various countries t discu s specific areas related to drug regulations and harmonization of pharmacopoeia.

(b): 24  countries  namely  India,  Germany,  France,  U.K.,  Netherlands,  Austria,  Belgiu Hungary, United States of America, Switzerland, Russia, Croatia, Cuba, Braz il, Malaysia, Japan, China,  Hong  Kong,  Thailand,  Sri  Lanka,  Kazakhstan,  Ghana,  Bangladesh  and  South  Africa (represented through a video link) participated in the Forum.

(c): The following major issues were discussed in the forum:

- Regulatory status and outlook of Homoeopathy in various countries.
- Enhancing synergies with traditional and conventional medicine systems.
- Homeopathic  Drug  Development  and  Regulatory  innovation  including  discussion  on Challenges and opportunities in new drug discovery and explo ring possibility of a new regulatory model and advances made in anthroposophic medicine.
- Harmonization of Homeopathic pharmacopoeias and encouraging Good Pharmacopoeial practices.
- Monograph/regulatory requirements covering strategic aspects with regard quantification of homeopathic preparations; ways to modernize monograph evaluation.

(d) The  details  of  the  Memorandum  of  Understanding  signed  between    Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) and Central Council for Research i n Homoeopathy (CCRH)  with Homoeopathic Pharmacopoeia Convention of the United States (HPCUS) on cooperation in the field of Homoeopathic Medicine  are as follows : -

- harmonisation of pharmacopeias of US and India;
- exchange and development of drug monograp hs;
- harmonization of protocol for drug validation;
- harmonization in standardization and regulation of homoeopathic drugs

(e): The manufacturing and sale of homoeopathic drugs is regulated  as per the provisio Drug and Cosmetic Rules, 1945 that i ncludes Good Manufacturing Practices.

Government has laid down Pharmacopoeial standards and published those in the form o individual drug monographs for use as benchmark for quality assessment of raw material b State Drug Controllers.

***********